Lupus Capital PLC
27 July 2007
27 July 2007
LUPUS CAPITAL PLC
LUPUS TRADING UPDATE FOR 6 MONTHS TO 30 JUNE 2007
Lupus is pleased to report that the group is trading in line with expectations.
Gall Thomson, the manufacturer of breakaway couplings, has enjoyed buoyant
markets in the first six months of 2007 and is expected to deliver record
performance both in sales, profits and cash generation.
Schlegel, a leader in the global manufacture and marketing of door and window
seals, has produced good results leading on from the operational initiatives
that were taken following its acquisition in April 2006.
Schlegel US is now being combined with the US door and window seal division of
Laird Group under a single management team to increase their prospects and
profitability. Many synergies will follow which will include a fully
comprehensive product range for their customers, greater purchasing power for
raw material sourcing, operational cost savings, the closure of one
manufacturing facility and increased product development.
Schlegel (non US) continues to thrive with good growth coming from the European
markets of Germany, Spain, UK and Eastern areas. The management of Linear, the
Laird UK seals company, has now been taken on by our Schlegel team which has
produced many cost saving opportunities resulting from optimising production
allocation between countries and also improving customer service.
Laird Security Systems, a division acquired from the Laird Group on 27 April
2007, is a manufacturer of products such as locks, handles, hinges and balances
for the US and UK door and window industry. Sales are approximately 60 per cent
to the refurbishment/remodelling (RMI) market and the remainder to new build.
RMI has been steady throughout the world in contrast to the US new build market,
which is subject to lower housing starts and completions. Cost reductions,
improved marketing and careful control of working capital have been necessary in
order to retain an acceptable level of profitability in the US. In the UK,
where the market is stronger, there are also many opportunities for similar
actions.
Input prices for raw materials are still high, although more stable than a year
ago. The dollar/pound exchange rate at over 2 is not favourable when converting
US profits. At the corporate level, however, the currency exposure has been
mitigated by designating a substantial portion of the debt taken on for the LSS
acquisition in US dollars. We continue to examine ways to optimise our
worldwide tax position and expect some success in achieving this.
Overall, we feel optimistic about the progress and prospects for the group and
we look forward to another period of strong performance and the further
development of Lupus Capital plc.
Enquiries to:
Greg Hutchings 020 7976 8000
Alan Frame 020 7405 7777
Nick Donald (HSBC - Nomad) 020 7991 8888
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.